Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Abstract
No abstract available
Funding Information
  • Medac GmbH
  • National Cancer Institute and National Heart Lung Blood Institute (CA100394, HL036444, and HL088021)

This publication has 53 references indexed in Scilit: